PW Consulting: Licorice Extract Market to Grow at 5.4% CAGR, Reach USD 300.6 Million by 2032

Licorice Extract Market 2026: Strategic Preview for Decision-Makers

As PW Consulting’s Senior Strategic Advisor and Chief Industry Analyst, I present a high-level yet actionable primer on the licorice extract market intended to orient corporate decision-making in 2026. This piece synthesizes our research findings, highlights the strategic implications of observable trends, and previews the operational intelligence contained in our full market study. The purpose is to build confidence in our analytical depth while intentionally withholding granular segmentation tables and proprietary price curves—precisely to direct executives and strategy teams to the full report for investment-grade detail.
Licorice Extract Market

Executive snapshot: why licorice extract matters to strategy teams in 2026

The licorice extract market has transitioned from a niche botanical commodity into a cross-sector functional ingredient with distinct commercial levers. From confectionery and beverage formulators to nutraceutical, cosmetic, and pharmaceutical product developers, buyers now treat licorice derivatives as both a flavor and a bioactive input. In value terms, the market continues to expand: with a 2025 base and a forecast trajectory extending through 2032, our model projects sustained mid-single-digit compound annual growth (CAGR 5.4%). The market is sizable enough to support differentiated producers and consolidated enough—with the top three and top five suppliers commanding meaningful shares—to make supply-side plays commercially attractive.
Licorice Extract Market

Market trajectory and structural drivers

• Growth posture: Post-2025, the market is forecast to grow at an approximate mid-single-digit CAGR to 2032, reflecting steady demand across multiple end-use industries and incremental adoption of licorice-derived functional ingredients in value-added food and health applications.
  Licorice Extract Market

• Demand vectors: Growth is being pulled by three concurrent dynamics—(1) reformulation of consumer-packaged goods for clean-label and natural flavor profiles; (2) expanded use in functional foods and approved functional claims in select jurisdictions; and (3) ongoing interest from pharmaceutical and nutraceutical manufacturers in standardized extracts for clinical and wellness use.

• Consolidation and concentration: Market concentration metrics indicate a competitive landscape where a small cohort of established players captures a meaningful slice of total market value. This creates both barriers and opportunities: scale and quality assurance matter, but niche product differentiation can win high-margin pockets.

What the full report contains (practical, operational intelligence)

Our complete market study is built for strategists, commercial teams, and M&A professionals who need executable inputs. Highlights include:

• Market sizing and trend maps: historical series, base-year validation, and forward-looking scenarios by product form and application (note: segmented breakdowns and proprietary price curves are available only in the full report).

• Demand-side playbook: buyer archetypes, specification demands (e.g., purity, glabridin content, solubility), and formulation-led adoption thresholds for F&B, pharmaceuticals, cosmetics, and nutraceuticals.

• Supply-side diagnostics: export/import dependency mapping, primary sourcing footprints, processing bottlenecks, and a supplier quality matrix to support supplier selection and qualification.

• Commercial benchmarking: go-to-market strategies, pricing bands, and contract archetypes for spot vs. long-term procurement.

• Risk and regulatory compliance checklist: jurisdictional labeling and active-ingredient caps, plus compliance pathways for innovative functional claims.

• Scenario playbooks for sourcing disruption, raw-material price volatility, and rapid demand shocks—each with tactical response templates for procurement, R&D, and sales.

Competitive landscape: strategic profiles and moves to watch

The market features a mix of regional specialists and global suppliers. The competitive set includes long-established botanical extractors, integrated ingredient houses, and a handful of firms pursuing functional-food claims. Key strategic profiles:

• Norevo GmbH (Germany): Known for a broad form-factor offering—powder, granules, paste and block formats—Norevo positions itself as a confectionery and food-focused supplier with an emphasis on product form innovation and low-dust formats attractive to manufacturing lines seeking hygiene improvements.

• MAFCO Worldwide LLC (U.S.): A global leader supplying pure derivatives and extracts, MAFCO combines scale with product breadth and is a preferred partner for large beverage and personal-care formulators requiring reliable supply and documentation.

• F&C Licorice Ltd. (Israel): A vertically integrated producer with deep exposure to tobacco, confectionery and pharmaceutical customers. Their strength is custom formulation and large-batch capability for industrial users.

• Geographic specialists (Iran, China, India, Japan, U.K.): Firms from key producing regions maintain cost and botanical access advantages, while Japan-based players have recently pursued differentiated functionality and regulatory approval strategies for weight-management and similar claims.

• Innovation plays: A number of companies have pivoted from commodity extract production toward standardized, bioactive-enriched fractions intended for health claims—creating a two-tier market of commodity vs. high-value functional extracts.

Noteworthy competitive developments in early 2026 illustrate strategy in motion: a leading European supplier refreshed its product catalog emphasizing lower-dust confectionery-friendly formats, while a Japanese pharmaceutical firm launched a proprietary licorice powder targeted at body-fat management under a regulated functional-food approval. These moves accelerate demand for certified, standardized extracts and underline the value of regulatory positioning as a moat.

Regulatory, raw-material and trade dynamics that shape strategy

• Regulatory pathways: In several mature markets, licorice is explicitly codified within flavor and food-ingredient frameworks, creating a clearer route-to-market for food and beverage producers who favor regulatory certainty. At the same time, labeling obligations and safety thresholds for glycyrrhizin content create formulation constraints that must be managed proactively in product design.

• Quality and compliance as differentiators: Suppliers that can provide batch-level analytical certification, low-impurity profiles, and validated glycyrrhizin content have a commercial edge with quality-sensitive buyers—particularly in pharma and nutraceutical channels.

• Supply volatility: Primary raw-material supply exhibits periodic volatility and geopolitical exposure. Strategic purchasers should model multi-source procurement, hedging strategies, and nearshoring of critical processing to mitigate disruption risk.

• Trade dynamics: Cross-border flows remain material to market balance. Import dependency in key consuming regions means trade policy and logistics shifts can quickly reprice the market—an input for scenario planning and contract design.

Strategic implications and recommended moves for 2026 planning

For corporate leadership teams preparing budgets, sourcing plans, and M&A pipelines in 2026, we recommend a layered approach:

• Prioritize supply assurance: Lock in multi-year contracts with quality clauses, diversify origin sources, and pursue backward integration where feasible for critical formulations.

• Pursue product differentiation: Invest in standardized, bioactive-enriched extracts and validated clinical or functional claims where regulatory pathways permit—this lifts margins and creates defensibility against commodity competitors.

• Targeted M&A and partnerships: Look for tuck-in acquisitions that add standardized processing, analytical capabilities, or regulatory dossiers to accelerate market entry into high-value subsegments.

• Operationalize regulatory readiness: Build lab and documentation capabilities that align with labeling thresholds and safety caps to shorten time-to-market for new formulations.

• Embed scenario planning in procurement: Use volatility scenarios (supply shocks, logistics delays, rapid demand swings) to stress-test commercial assumptions and to design contingency sourcing playbooks.

Methodology and rigor

The findings summarized here are based on a base-year of 2025, a historical review covering 2020–2025, and a forecast horizon extending to 2032. Our approach combines bottom-up revenue modelling, supplier and buyer interviews, customs and trade data triangulation, and regulatory analysis to produce scenario-bound forecasts and a set of practical response options. Where the full report refrains from publishing certain granular data in this preview, it is to preserve commercial sensitivity and to ensure readers access validated, source-linked tables and company scorecards behind a single authoritative wall.

Final note: the strategic value of the full study

This preview establishes the qualitative contours and core strategic choices the licorice extract market presents in 2026. The full PW Consulting study contains the actionable maps—supplier scorecards, segment-level demand estimates, contractual templates, and sensitivity-tested price curves—needed to convert insight into execution. For teams preparing capital allocation, supply-chain redesign, or product-innovation roadmaps, the complete report is designed to cut through ambiguity and provide the verifiable inputs required to make confident decisions.

Contact PW Consulting to access the full market dossier, including the proprietary segment matrices and decision-ready annexes that underpin the recommendations above.

For detailed analysis of this topic, please visit the official page: Licorice Extract Market

Lacy Lee
Senior Marketing Manager
sales@pmarketresearch.com
00852-95632430
PW Consulting: www.pmarketresearch.com